产品详情
靶点信息
JAK2 | JAK2 | |||
0.45 nM(Ki) | <3 nM |
In vitro | DMSO | 70 mg/mL (197.54 mM) | |
Water | Insoluble | ||
Ethanol | 3 mg/mL (8.46 mM) | ||
* <1 mg/ml means slightly soluble or insoluble. * Please note that Adooq tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations. |
Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
---|---|---|---|
0.1 mM | 28.22 mL | 141.08 mL | 282.17 mL |
0.5 mM | 5.64 mL | 28.22 mL | 56.43 mL |
1 mM | 2.82 mL | 14.11 mL | 28.22 mL |
5 mM | 0.56 mL | 2.82 mL | 5.64 mL |
*The above data is based on the productmolecular weight 354.4 . Batch specific molecular weights may vary from batch to batch due to solvent of hydration, which will affect the solvent volumes required to prepare stock solutions.
目录号 | A10104 |
---|---|
作用机制 | Inhibitor (抑制剂) |
M. Wt | 354.4 |
Formula | C18H16F2N6 |
Purity | >99% |
Storage | Store lyophilized at -20ºC, keep desiccated. |
CAS No. | 905586-69-8 |
Synonyms | AZ960 |
SMILES | CC1=CC(=NN1)NC2=C(C=C(C(=N2)N[C@@H](C)C3=CC=C(C=C3)F)C#N)F |
产品标签
Product Questions
Product Questions
Pexidartinib (PLX3397)
Pexidartinib (PLX3397)是KIT,CSF1R和FLT3的小分子酪氨酸激酶(RTK)抑制剂,具有潜在的抗肿瘤活性。
SGI-1776 (free base)
SGI-1776 (free base)是Pim1的一种新型ATP竞争性抑制剂,在无细胞试验中的IC50为7 nM,选择性是Pim2和Pim3的50倍和10…
VX-680 (MK-0457, Tozasertib)
VX-680 (MK-0457,Tozasertib)是一种有效的选择性Aurora激酶小分子抑制剂。
BMS-911543
BMS-911543是一种有效的、选择性JAK2小分子抑制剂。
Filgotinib
Filgotinib是一种选择性的JAK1抑制剂,对于JAK1,JAK2,JAK3和TYK2的IC50分别为10 nM,28 nM,810 nM和116 nM。